Developer docs
API playgroundTry for free, no card

Search company profiles

Androlabs

Full company profile

uuid002grvb

Namestring
Androlabs
Legal namestring
Androlabs
Websiteurl
andro-labs.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Androlabs is a London-based specialty pharmaceutical company, founded in 2021, that positions itself as the first global pharmaceutical firm dedicated exclusively to men's health. Its commercial portfolio is built on two therapeutic pillars: testosterone replacement therapy (TRT) for men with low testosterone, and pharmaceutical treatments for erectile dysfunction. Products are sold under the Androlabs brand through healthcare-professional channels — the company runs a dedicated, gated Healthcare Professional Zone offering CPD, research summaries, podcasts and patient resources — rather than via direct-to-consumer retail, indicating an enterprise/B2B motion to prescribers, urologists, endocrinologists and pharmacies.

The company's business model is straightforward specialty-pharma product sales to healthcare providers and, through them, to patients. Pricing is not publicly disclosed and is handled via a supply query channel (info@androlabs.com), consistent with negotiated distribution arrangements rather than list-price retail. Revenue mechanics therefore depend on supply agreements, prescriber uptake and geographic rollout rather than on per-seat software contracts or subscription pricing.

Beyond the core pharmaceutical offering, Androlabs invests in a complementary ecosystem: the TRTed community (trted.org), an evidence-based online community for men addressing knowledge gaps in men's health, and 'The Brothers' Arms' newsletter. The stated strategic intent — articulated on the company website — is to expand the product offering beyond TRT and ED to cover a broader set of men's health indications. Headcount is reported at 11–50 employees; no funding rounds, investors, revenue figures, named customers, patents, awards, partnerships or leadership team details beyond the two founders (Charlie Bryant, co-founder; Nicolas Vennin, founder) are disclosed in the available material.

Short descriptiontext

Androlabs is a London-based pharmaceutical company and the first globally to focus exclusively on men's health. It markets testosterone replacement therapy and erectile dysfunction treatments through healthcare professionals, supported by the TRTed patient community and HCP education resources.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
men's health pharmaceuticals, testosterone replacement therapy, erectile dysfunction treatment, hormone therapy products, specialty pharmaceutical medications
Industry3 codes
PRIMARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAH
Nephrology & Urology Specialty Pharmaceuticals
SECONDARYHLAKAOAD
Male Reproductive & Sexual Medicine (Andrology)
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Men's Health Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Androlabs generates revenue through the sale of pharmaceutical products including testosterone replacement therapy and erectile dysfunction medications. As a pharmaceutical company, revenue is derived from product sales to healthcare providers and patients.

androlabs.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1TRTed
Description

An inclusive community dedicated to addressing knowledge gaps and providing evidence-based resources on men's health issues.

androlabs.com
Core offering1 text field

Androlabs is the first global pharmaceutical company solely focused on men's health, developing and commercializing Testosterone Replacement Therapy (TRT) and Erectile Dysfunction (ED) therapies. Its portfolio is supported by an Education & Support function and the TRTed patient community, with a dedicated Healthcare Professional Zone serving clinicians and prescribers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Androlabs is the first global pharmaceutical company dedicated to men's health, operating as a single-brand pharmaceutical company. The company offers a portfolio centered on two core therapeutic areas: Testosterone Replacement Therapy and Erectile Dysfunction Therapies. These pharmaceutical products are supported by complementary Education & Support services and the TRTed Community platform, which provides evidence-based resources and a community forum for men dealing with men's health issues. The portfolio is designed to address the male life expectancy gap through comprehensive pharmaceutical and educational offerings.

Product and service2 records
1Testosterone Replacement Therapy
CategoryMen's Health Pharmaceuticals
Description

Pharmaceutical therapy for men with testosterone deficiency, prescribed and dispensed through healthcare professionals and medical institutions as part of Androlabs' men's health portfolio.

2Erectile Dysfunction Therapies
CategoryMen's Health Pharmaceuticals
Description

Pharmaceutical treatments for erectile dysfunction in men, prescribed and dispensed through healthcare professionals and medical institutions as part of Androlabs' men's health portfolio.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Androlabs

Men's Health Pharmaceuticalsandro-labs.com

Androlabs is a London-based pharmaceutical company and the first globally to focus exclusively on men's health. It markets testosterone replacement therapy and erectile dysfunction treatments through healthcare professionals, supported by the TRTed patient community and HCP education resources.

What Androlabs does

Androlabs is a London-based specialty pharmaceutical company, founded in 2021, that positions itself as the first global pharmaceutical firm dedicated exclusively to men's health. Its commercial portfolio is built on two therapeutic pillars: testosterone replacement therapy (TRT) for men with low testosterone, and pharmaceutical treatments for erectile dysfunction. Products are sold under the Androlabs brand through healthcare-professional channels — the company runs a dedicated, gated Healthcare Professional Zone offering CPD, research summaries, podcasts and patient resources — rather than via direct-to-consumer retail, indicating an enterprise/B2B motion to prescribers, urologists, endocrinologists and pharmacies.

The company's business model is straightforward specialty-pharma product sales to healthcare providers and, through them, to patients. Pricing is not publicly disclosed and is handled via a supply query channel (info@androlabs.com), consistent with negotiated distribution arrangements rather than list-price retail. Revenue mechanics therefore depend on supply agreements, prescriber uptake and geographic rollout rather than on per-seat software contracts or subscription pricing.

Beyond the core pharmaceutical offering, Androlabs invests in a complementary ecosystem: the TRTed community (trted.org), an evidence-based online community for men addressing knowledge gaps in men's health, and 'The Brothers' Arms' newsletter. The stated strategic intent — articulated on the company website — is to expand the product offering beyond TRT and ED to cover a broader set of men's health indications. Headcount is reported at 11–50 employees; no funding rounds, investors, revenue figures, named customers, patents, awards, partnerships or leadership team details beyond the two founders (Charlie Bryant, co-founder; Nicolas Vennin, founder) are disclosed in the available material.

Androlabs firmographics

Firmographics
Name
Androlabs
Legal name
Androlabs
Website
https://andro-labs.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Androlabs is a London-based pharmaceutical company and the first globally to focus exclusively on men's health. It markets testosterone replacement therapy and erectile dysfunction treatments through healthcare professionals, supported by the TRTed patient community and HCP education resources.
Ownership category
akta.pro rank

Androlabs industry classification

Industry
Product category
Men's Health Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAH
Nephrology & Urology Specialty Pharmaceuticals
SECONDARYHLAKAOAD
Male Reproductive & Sexual Medicine (Andrology)

Keywords

  • Men's health pharmaceuticals
  • Testosterone replacement therapy
  • Erectile dysfunction treatment
  • Hormone therapy products
  • Specialty pharmaceutical medications

Where Androlabs is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Androlabs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Androlabs generates revenue through the sale of pharmaceutical products including testosterone replacement therapy and erectile dysfunction medications. As a pharmaceutical company, revenue is derived from product sales to healthcare providers and patients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Androlabs product offering

Product offering

Core offering

Androlabs is the first global pharmaceutical company solely focused on men's health, developing and commercializing Testosterone Replacement Therapy (TRT) and Erectile Dysfunction (ED) therapies. Its portfolio is supported by an Education & Support function and the TRTed patient community, with a dedicated Healthcare Professional Zone serving clinicians and prescribers.

Product overview

Androlabs is the first global pharmaceutical company dedicated to men's health, operating as a single-brand pharmaceutical company. The company offers a portfolio centered on two core therapeutic areas: Testosterone Replacement Therapy and Erectile Dysfunction Therapies. These pharmaceutical products are supported by complementary Education & Support services and the TRTed Community platform, which provides evidence-based resources and a community forum for men dealing with men's health issues. The portfolio is designed to address the male life expectancy gap through comprehensive pharmaceutical and educational offerings.

Differentiator

Problem solved

Functional benefit

Brands

  • TRTed: An inclusive community dedicated to addressing knowledge gaps and providing evidence-based resources on men's health issues.

Products and services

  • Testosterone Replacement Therapy Pharmaceutical therapy for men with testosterone deficiency, prescribed and dispensed through healthcare professionals and medical institutions as part of Androlabs' men's health portfolio.
  • Erectile Dysfunction Therapies Pharmaceutical treatments for erectile dysfunction in men, prescribed and dispensed through healthcare professionals and medical institutions as part of Androlabs' men's health portfolio.

Companies that use Androlabs

Customer profile

Segments2 records

Ideal customer profiles2 records

Androlabs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Androlabs partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights5 records

Androlabs competitors and assessment

Company assessment

Market position

Strengths1 record

Weaknesses1 record

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Androlabs social profiles

Digital presence

Androlabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Androlabs leadership team

Management profile

Number of profiles

Profiles2 records

Androlabs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Androlabs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Androlabs

What does Androlabs do?

Androlabs is the first global pharmaceutical company solely focused on men's health, developing and commercializing Testosterone Replacement Therapy (TRT) and Erectile Dysfunction (ED) therapies. Its portfolio is supported by an Education & Support function and the TRTed patient community, with a dedicated Healthcare Professional Zone serving clinicians and prescribers.

Is Androlabs a public or private company?

Androlabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Androlabs founded?

Androlabs was founded in 2021. It employs 11 to 50 people.

Where is Androlabs based?

Androlabs is headquartered in London, United Kingdom, in the Europe region.

How does Androlabs make money?

One revenue line is on record: pharmaceutical Product Sales.

Does Androlabs have an API?

No public API is recorded for Androlabs.

What industry is Androlabs in?

Androlabs's product category is Men's Health Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health), with a secondary code of HLAIACAH, Nephrology & Urology Specialty Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals